Population: Adults (18-64 years)

MIViral

Switzerland
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Respiratory syncytial virus infection
  • Influenza
  • COVID-19

Joseph

Switzerland
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Lihou

United Kingdom
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Herder

Sweden
|
2018-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Chlamydia
  • Gonorrhea

Urban

Austria
|
2020-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Hospital
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Hepatitis B
  • Hepatitis C
  • Sexually transmitted infection
  • Syphilis
  • Chlamydia
  • Gonorrhea
  • HIV

M-BOOST-FR

France
|
2025-2027
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Serum
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Crandell

Portugal Brazil
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Blood sample
  • PBMC
  • Pharmacological intervention
  • Vaccination
  • JYNNEOS
  • Dryvax

Packer

United Kingdom
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Community
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection

Martínez-Arias

Spain
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Primary care
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection

Drennan

United Kingdom
|
2022-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • STD/STI clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Pharmacological intervention
  • Vaccination

Caldrer

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Blood sample
  • Serum sample

STIMULATE-ICP

United Kingdom of Great Britain and Northern Ireland
|
2022
  • Adults (18-64 years)
  • General population
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Colchicine
  • Antihistamines
  • Rivaroxaban